12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant price movements. Ensysce Biosciences, CalciMedica, Matinas BioPharma, AtriCure, Cue Biopharma, and HOOKIPA Pharma saw notable gains, while Applied DNA Sciences, AnaptysBio, Spero Therapeutics, GlycoMimetics, Tempest Therapeutics, and CVRx experienced declines.
October 30, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AtriCure stock increased by 15.52% to $34.0 following Q3 earnings release.
The stock's increase is likely due to positive reception of the Q3 earnings report.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
CalciMedica stock rose 18.32% to $4.65, reflecting positive market sentiment.
The rise in stock price indicates strong investor interest, possibly due to favorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Cue Biopharma stock rose 15.38% to $1.95, indicating strong market interest.
The stock's rise suggests positive investor sentiment, possibly due to favorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Ensysce Biosciences shares increased by 21.6% to $0.5, indicating strong pre-market interest.
The significant price increase suggests positive sentiment or news influencing investor behavior.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
HOOKIPA Pharma shares increased by 14.47% to $4.27, reflecting positive market sentiment.
The stock's rise suggests positive investor sentiment, possibly driven by recent news or expectations.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Matinas BioPharma shares increased by 18.27% to $3.3, showing strong pre-market performance.
The stock's rise suggests positive investor sentiment, possibly driven by recent news or expectations.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
AnaptysBio shares fell 21.43% to $24.2, reflecting negative market sentiment.
The decline suggests negative investor sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Applied DNA Sciences stock fell 41.7% to $0.18, indicating significant negative sentiment.
The sharp decline suggests negative news or sentiment affecting investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
CVRx shares fell 11.92% to $9.46 following Q3 earnings release.
The stock's decline is likely due to negative reception of the Q3 earnings report.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
GlycoMimetics stock fell 14.31% to $0.42, reflecting negative market sentiment.
The decline suggests negative investor sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Spero Therapeutics stock decreased by 19.85% to $1.05, indicating negative sentiment.
The stock's decline suggests negative investor sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Tempest Therapeutics shares declined by 13.65% to $0.95, indicating negative sentiment.
The stock's decline suggests negative investor sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80